Subscribe: Food and Drug Administration--Press Releases
http://www.fda.gov/bbs/topics/news/rssPress.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
administration today  administration  approved  drug administration  drug  fda approves  fda  food drug  food  new  patients  today  zika virus 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Food and Drug Administration--Press Releases

Food and Drug Administration--Press Releases



Press releases from FDA



Last Build Date: Fri, 02 Dec 2016 13:04:00 -0500

 



FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

Fri, 02 Dec 2016 13:04:00 -0500

The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.



Food regulators seize adulterated milk products for food safety violations

Wed, 30 Nov 2016 17:29:00 -0500

The U.S. Food and Drug Administration announced today that the U.S. Marshals Service seized more than 4 million pounds of product produced by Valley Milk Products LLC (Valley Milk) of Strasburg, Virginia.



FDA research to help speed development of Zika virus vaccines and therapeutics

Thu, 17 Nov 2016 14:04:00 -0500

A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics. Published today in PLoS Pathogens, is the description of a neonatal mouse model that provides a platform for potentially improving and expediting studies to understand the causes and effects (pathology) of the Zika virus.



FDA approves Intrarosa for postmenopausal women experiencing pain during sex

Thu, 17 Nov 2016 09:23:00 -0500

The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA).



FDA approves new device for prevention of recurrent strokes in certain patients

Fri, 28 Oct 2016 13:18:00 -0400

The U.S. Food and Drug Administration today approved the Amplatzer PFO Occluder device. The PFO Occluder reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot that passed through a small hole in the heart, called a patent foramen ovale (PFO), and then traveled to the brain.



FDA grants accelerated approval to new treatment for advanced soft tissue sarcoma

Wed, 19 Oct 2016 13:51:00 -0400

The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues. Lartruvo is approved for use with the FDA-approved chemotherapy drug doxorubicin for the treatment of patients with STS who cannot be cured with radiation or surgery and who have a type of STS for which an anthracycline (chemotherapy) is an appropriate treatment.



FDA awards 21 grants to stimulate product development for rare diseases

Mon, 17 Oct 2016 12:38:00 -0400

The U.S. Food and Drug Administration today announced that it has awarded 21 new clinical trial research grants totaling more than $23 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry with research spanning domestic and international clinical sites.